The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2364165
WO Application Number:
US2009064060
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09756209.4
WO Publication Number:
WO2010056765
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
11/11/2009
Grant date:
03/01/2018
EP Publication Date:
14/09/2011
WO Publication Date:
20/05/2010
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/01/2018
EP B1 Publication Date:
03/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/11/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
03/01/2018
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
03/01/2018
Name:
Portola Pharmaceuticals, Inc.
Address:
270 East Grand Avenue Suite 22, SOUTH SAN FRANCISCO CALIFORNIA 94080, United States of America (US)
Inventor
1
Name:
LU, Genmin
Address:
Burlingame
California 94010, United States of America (US)
2
Name:
SINHA, Uma
Address:
San Francisco
California 94124, United States of America (US)